CD8A and neoplasm: We hypothesize that the ability of LND-CDNs to optimally activate DCs by being in the right place (co-localized with DCs and tumour cells) at the right time (during and following tumour cell death) leads to more effective CD8 T-cell priming and eventual tumour rejection.